Medical Assistance
Receive guidance from the first consultation through the entire hospitalization process.
0
How does Myriad conduct BART testing?
- 1 people answered
0 Vote
1 Contributor
1042 Views 
0 Saved 0 Vote 1 Contributor1042 Views 0 SavedYou might also be interested in
Do you have a blue vein in your breast? If so, it may be nothing but a cosmetic problem. In most of the cases are harmless and tend to fade by themselves. Sometimes, however, blue veins in breasts can indicate the presence of an underlying medical condition. It is normal for you to worry if you not....
Surgery is only the first step towards fuller and more beautiful breasts. Following your breast enhancement surgery, the recovery period is a crucial time during which your body heals and your new breast implants settle into their proper position and shape. Following Breast Implant surgery you ca....
Dear sir, I have suffering from Peptic ulcer from 7 years back and still now, if there any treatment from ur hand so please kindly suggest me.
Mahima Chaudhary
Imagine going in for a cancer screening, and the technician turns to you and says, "We're finished, but if I push this button over here, the machine can detect even smaller cancers. But here's the hitch: You have to pay $700 if you want me to push this button."
Myriad Genetics is doing something very similar with BART tests that determine if a woman has a potentially dangerous genetic abnormality linked to breast cancers.
When testing shows that a woman carries a bad gene, she has a much higher chance of getting breast cancer. These women usually then get more frequent MRIs, ultrasounds and mammograms to detect cancer.
Myriad owns the patent on breast cancer genes and so is the only company that can test for them. It offers one test that catches most, but not all, abnormalities, and then charges nearly all patients $700 for a second test that catches the rest.
If a woman can't afford the $700 fee, she may miss an abnormality, which could mean the difference between life and death.
Myriad defends the $700 charge for its second test, called BART, even though many patients can't afford it and insurance won't pay for it.